What is the clinical evidence from this study?

Study design: Letter. Population: Critically ill cancer.

What question did this study set out to answer?

To clarify the implications of frailty and vulnerability as measured by clinical frailty scale cutoffs in critically ill cancer patients.

March 22, 2026Indian Journal of Critical Care Medicine0 citationsOpen Access

Author Response: Frailty or Vulnerability? Interpreting Clinical Frailty Scale Cutoffs in Critically Ill Cancer Patients

SSSuresh Kumar SundaramurthyApollo Hospitals NRNagarajan RamakrishnanApollo Hospitals RSRaymond Dominic Savio

Key Result

Reclassifying a Clinical Frailty Scale score of 4 as very mild frailty had minimal impact on overall frailty prevalence, affecting only 1.1% (7 patients) of the critically ill cancer cohort.

Key Points

To clarify the implications of frailty and vulnerability as measured by clinical frailty scale cutoffs in critically ill cancer patients.
Reviewed clinical frailty scale cutoffs
Analyzed patient outcomes related to frailty levels
Discussed implications for critical care management
Identified specific frailty cutoff values affecting patient outcomes
Found strong associations between frailty levels and treatment responses
Demonstrated variability in interpretation of frailty and vulnerability metrics

PICO

Population

Critically ill cancer

Limitations

Primarily descriptive study
Lack of alternative frailty thresholds and sensitivity analyses

Abstract

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Sundaramurthy et al. (Wed,) conducted a letter in Critically ill cancer. Reclassifying a Clinical Frailty Scale score of 4 as very mild frailty had minimal impact on overall frailty prevalence, affecting only 1.1% (7 patients) of the critically ill cancer cohort.

synapsesocial.com/papers/69bf8641f665edcd009e8c6d https://doi.org/https://doi.org/10.5005/jp-journals-10071-25168

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper